Equipped with the Molecular Biology Laboratory and Cell Biology Laboratory, with VICTOR X4 multi-function microplate reader, QuanStudio Dx RTPCR, AZURE Sapphire dual-mode multispectral laser imaging system, GUAVA 6HT flow cytometer, Nikon TI-S inverted fluorescence microscope and other equipment, can complete a variety of tests at the molecular level and cellular level. At present, it has many platforms such as anti-tumor drug R&D, metabolic regulatory drug R&D, antibiotics, pain and neurodegenerative drug R&D. It involves targeted anti-tumor projects, immunomodulatory anti-tumor projects and combined chemotherapy and radiotherapy anti-tumor projects. It can quickly and accurately carry out target confirmation, mechanism research, rapid screening of early compounds, and in vivo and vitro comprehensive efficacy evaluation of candidate compounds, development experiments of IND application, and exploration of compound combination or new indications in clinical stage.

BSL-2 laboratory obtained the approval of the city health bureau and successfully put the record, can carry out three and four classes of pathogenic microorganisms, established the ultra-low temperature bacteria library and frozen-dried the bacterial strain library, can be a full set of body and in vitro anti-infection drug screening and development work. Preclinical pharmacodynamic studies of anti-infectious agents and writing of this submission can conducted per NMPA and FDA requirements.

It has a fully functional cell biology laboratory, accumulated nearly 100 cell repositories, can carry out conventional cell 2D, 3D culture and proliferation inhibition experiments, mechanism verification related biomarker confirmation test, and can conduct a large number of cell expansion, support xenograft tumor model and homologous mouse tumor model efficacy evaluation experiment. Preclinical pharmacodynamic studies of anti-infectious agents and writing of this submission can conducted per NMPA and FDA requirements.